Physician profile
Robert Matthew Brenner
NPI 1366862971
$83,123.98
in general payments reported to CMS, 2019-2025
9 companies · $1,841 in 2025
The $1,841 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77K · 2020: $448 · 2021: $315 · 2022: $3,801 · 2024: $177 · 2025: $1,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264 · Travel and Lodging: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.22 |
| Travel and Lodging | $753.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $75,285.28 | 2019-2021 | |
| Alphatec Spine, INC | $3,756.32 | 2022 | |
| Medtronic USA, INC. | $1,702.14 | 2019-2020 | |
| Globus Medical, INC. | $1,425.25 | 2025 | Xlif, Senza, Excelsius Gps |
| Medtronic, INC. | $599.30 | 2021-2025 | Mazor X System, Stealthstation S8 Platform |
| Nevro Corp. | $157.02 | 2024 | Senza |
| Stryker Corporation | $129.10 | 2020 | |
| Biedermann Motech, INC. | $50.07 | 2020 | |
| Carlsmed, INC. | $19.50 | 2024 | Aprevo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brenner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.